Regenerative Medical Technology Group Inc.
RMTG
$0.04
$0.003.00%
OTC PK
| 03/31/2026 | 09/30/2025 | 06/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | 56.87% | 68.65% | 68.65% | 90.70% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | 56.87% | 68.65% | 68.65% | 90.70% |
| Cost of Revenue | -- | 117.01% | 78.08% | 78.08% | 98.77% |
| Gross Profit | -- | 32.21% | 64.41% | 64.41% | 87.25% |
| SG&A Expenses | -- | 28.27% | 31.10% | 31.10% | 26.65% |
| Depreciation & Amortization | -- | -55.14% | -52.82% | -52.82% | -40.68% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -- | 43.33% | 34.71% | 34.71% | 36.36% |
| Operating Income | -- | 70.48% | 169.20% | 169.20% | 148.92% |
| Income Before Tax | -- | -36.23% | 64.62% | 64.62% | 56.83% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -- | -36.23% | 64.62% | 64.62% | 56.83% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -- | -36.23% | 64.62% | 64.62% | 56.83% |
| EBIT | -- | 70.48% | 169.20% | 169.20% | 148.92% |
| EBITDA | -- | 436.66% | 572.38% | 572.38% | 262.95% |
| EPS Basic | -- | -35.75% | 64.84% | 64.84% | 57.05% |
| Normalized Basic EPS | -- | 1.11% | 52.60% | 52.60% | 42.03% |
| EPS Diluted | -- | -35.75% | 64.84% | 64.84% | 57.05% |
| Normalized Diluted EPS | -- | 1.11% | 52.60% | 52.60% | 42.03% |
| Average Basic Shares Outstanding | -- | 0.35% | 0.54% | 0.54% | 0.55% |
| Average Diluted Shares Outstanding | -- | 0.35% | 0.54% | 0.54% | 0.55% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |